Cardiovascular

Given the considerable impact that CVD has on many people's lives, it is no surprise that the demand for solutions is exploding. IDTechEx Research found that the market for cardiovascular disease technology will exceed $40 billion by the year 2030.

IDTechEx identifies top future technologies in healthcare. With demographic changes such as the aging of the population, they forecast there to be strong growth in technologies that help healthcare providers manage the growing burden on the healthcare system while maintaining high quality care.

Cardiovascular disease (CVD) must be better managed for patient care to improve. The protocols for monitoring patients are rapidly evolving. Historically, patients who fall ill are required to travel in order to visit a general practitioner or hospital. This procedure may soon become a thing of the past.

Diagnosing CVD is the first step in patients' road to recovery. It is imperative to detect the disease early in order to administer treatment while it is still treatable. In addition, preventing the disease altogether is becoming more important in healthcare. The main approaches for detecting CVD are currently in vitro diagnostics (IVD) at point-of-care (POC) and the use artificial intelligence (AI) in cardiovascular imaging.

Mobile cardiac telemetry (MCT), Holter monitoring, event monitoring and a comparison with other options